banner add

Ozempic Is About to Go Generic in India, China and Canada

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

from NYT > Health https://ift.tt/B25vaUK
via IFTTT

No comments

Short Naps, Long Hours: How Autism Clinics Squeeze Medicaid Dollars Out of Preschoolers

The industry has grown rapidly, straining state budgets. A focus on finances has led to overbilling, fraud and even harm. from NYT > He...

Theme images by PLAINVIEW. Powered by Blogger.